Cost-effectiveness of magnetic resonance imaging and targeted fusion biopsy for early detection of prostate cancer.
Christine L BarnettMatthew S DavenportJeffrey S MontgomeryJohn T WeiJames E MontieBrian T DentonPublished in: BJU international (2018)
Our analysis suggests MRI followed by targeted MRI/ultrasonography fusion biopsy can be a cost-effective approach to the early detection of PCa.